依類型篩選

Filter By  

2020/2/4 報告

Accelerating Immunotherapy Clinical Trials in Asia-Pacific

Over 600 sites across Asia-Pacific have been involved in the clinical development of now approved IO drugs, and hundreds more are experienced in managing clinical trials with immunotherapies for bo

下載
2022/12/8 報告

花生過敏 – 亞太地區 – 臨床試驗前景

與西方類似，澳洲在亞太地區的花生過敏率最高，影響約 3% 的兒童。

下載
2023/2/20 報告

類風溼性關節炎 - 全球臨床試驗概況 - 著重於亞太地區

印度與中國的類風溼性關節炎盛行率最高，分別有 1 千萬及 5 百萬例，且觀察到東亞的年齡標準化發生率和盛行率增加速度最快。

下載
2022/10/10 報告

C3G 腎絲球病變 (Glomerulopathy) – 亞太地 區 – 臨床試驗狀況

1990 年起至 2019 年間，亞洲地區腎絲球腎 炎 (Glomerulonephritis) 病症的年齡標準化發生率和 盛行率增加幅度遠勝西方地區，特別是南亞地區。

下載
  Associate Project Manager Program

JANUARY 2022 INTAKE – AUSTRALIA
  Proposals, Budgets and Contracts Graduate Program

January 2023 Intake - Malaysia 
  Clinical Research Associate (CRA) Essentials Program

JANUARY 2022 INTAKE – AUSTRALIA AND NEW ZEALAND We are internationally recognized as a leading regional ful
2013/5/31 新聞

Novotech appointed Contract Research Organisation for upcoming Phase 1b/2 study of HER-Vaxx in…

Imugene’s clinical review for HER-Vaxx is now complete HER-Vaxx Phase 1b/2 in gast

報告
2021/2/11 新聞

Celebrating International Day for Women and Girls in Science 2021

Thursday 11 February 2021

報告